Traws Pharma, Inc. — Director's Dealing 2014

Jul 9, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2014-07-07

Reporting Person: Hoffman Michael B (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-07-07	Common Stock	M	18754	$2.67	Acquired	18754	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-07-07	Stock Option (right to purchase)	$2.67	M	18754	Disposed	2016-04-01	Common Stock (18754)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4518275	Indirect
Common Stock	84350	Indirect

Footnotes

F1: These shares are held in trust for the benefit of the reporting person's descendants. The reporting person's spouse is a trustee of the trust.